Related references
Note: Only part of the references are listed.Amelioration of Brain Pathology and Behavioral Dysfunction in Mice With Lupus Following Treatment With a Tolerogenic Peptide
Smadar Lapter et al.
ARTHRITIS AND RHEUMATISM (2009)
Induction of mucosal tolerance in SLE: A sniff or a sip away from ameliorating lupus?
Henry Yim Wu
CLINICAL IMMUNOLOGY (2009)
Potential for anti-DNA immunoglobulin peptide therapy in systemic lupus erythematosus
Noriko Iikuni et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2009)
The tolerogenic peptide hCDR1 downregulates pathogenic cytokines and apoptosis and upregulates immunosuppressive molecules and regulatory T cells in peripheral blood mononuclear cells of lupus patients
Zev M. Sthoeger et al.
HUMAN IMMUNOLOGY (2009)
Treatment of lupus patients with a tolerogenic peptide, hCDR1 (Edratide): Immunomodulation of gene expression
Zev M. Sthoeger et al.
JOURNAL OF AUTOIMMUNITY (2009)
Suppression of murine SLE by oral anti-CD3: inducible CD4+CD25-LAP+ regulatory T cells control the expansion of IL-17+follicular helper T cells
H. Y. Wu et al.
LUPUS (2009)
Induction of immune tolerance by activation of CD8+ T suppressor/regulatory cells in lupus-prone mice
Brian J. Skaggs et al.
HUMAN IMMUNOLOGY (2008)
pConsensus peptide induces tolerogenic CD8+ T cells in lupus-prone (NZB x NZW)F1 mice by differentially regulating Foxp3 and PD1 molecules
Ram Pyare Singh et al.
JOURNAL OF IMMUNOLOGY (2008)
Nasal Anti-CD3 Antibody Ameliorates Lupus by Inducing an IL-10-Secreting CD4+CD25-LAP+ Regulatory T Cell and Is Associated with Down-Regulation of IL-17+CD4+ICOS+CXCR5+ Follicular Helper T Cells
Henry Yim Wu et al.
JOURNAL OF IMMUNOLOGY (2008)
The suppression of murine lupus by a tolerogenic peptide involves Foxp3-expressing CD8 cells that are required for the optimal induction and function of Foxp3-expressing CD4 cells
Amir Sharabi et al.
JOURNAL OF IMMUNOLOGY (2008)
Therapeutic T-cell manipulation in rheumatoid arthritis: past, present and future
J. D. Isaacs
RHEUMATOLOGY (2008)
The role of apoptosis in the ameliorating effects of a CDRI-based peptide on lupus manifestations in a mouse model
Amir Sharabi et al.
JOURNAL OF IMMUNOLOGY (2007)
CD8+ T cell-mediated suppression of autoimmunity in a murine lupus model of peptide-induced immune tolerance depends on Foxp3 expression
Ram Pyare Singh et al.
JOURNAL OF IMMUNOLOGY (2007)
Clinical amelioration of murine lupus by a peptide based on the complementarity determining region-1 of an autoantibody and by cyclophosphamide: similarities and differences in the mechanisms of action
Amir Sharabi et al.
IMMUNOLOGY (2007)
A peptide based on the complementarity-determining region 1 of an autoantibody ameliorates lupus by up-regulating CD4+CD25+ cells and TGF-β
Amir Sharabi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Amelioration of murine lupus by a peptide, based on the complementarity determining region-1 of an autoantibody as compared to dexamethasone: Different effects on cytokines and apoptosis
A Sharabi et al.
CLINICAL IMMUNOLOGY (2006)
Oral tolerance: Therapeutic implications for autoimmune diseases
Ana M. C. Faria et al.
CLINICAL & DEVELOPMENTAL IMMUNOLOGY (2006)
Tolerogenic treatment of lupus mice with consensus peptide induces Foxp3-expressing, apoptosis-resistant, TGFβ-secreting CD8+ T cell suppressors
BH Hahn et al.
JOURNAL OF IMMUNOLOGY (2005)
Peptide-based immunotherapy:: a novel strategy for allergic disease
F. Runa Ali et al.
EXPERT REVIEW OF VACCINES (2005)
Very low-dose tolerance with nucleosomal peptides controls lupus and induces potent regulatory T cell subsets
HK Kang et al.
JOURNAL OF IMMUNOLOGY (2005)
Antigen-specific therapies in multiple sclerosis: Going beyond proteins and peptides
P Fontoura et al.
INTERNATIONAL REVIEWS OF IMMUNOLOGY (2005)
Ig-reactive CD4+ CD25+ T cells from tolerized (New Zealand Black x New Zealand White)F1 mice suppress in vitro production of antibodies to DNA
A La Cava et al.
JOURNAL OF IMMUNOLOGY (2004)
Histone peptide-induced nasal tolerance: Suppression of murine lupus
HY Wu et al.
JOURNAL OF IMMUNOLOGY (2002)
A peptide DNA surrogate accelerates autoimmune manifestations and nephritis in lupus-prone mice
E Beger et al.
JOURNAL OF IMMUNOLOGY (2002)
Oral administration of an apo A-I mimetic peptide synthesized from D-amino acids dramatically reduces atherosclerosis in mice independent of plasma cholesterol
M Navab et al.
CIRCULATION (2002)
The mechanism by which a peptide based on complementarity-determining region-1 of a pathogenic anti-DNA auto-Ab ameliorates experimental systemic lupus erythematosus
E Eilat et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
γδ T cells as mediators of mucosal tolerance:: the autoimmune diabetes model
A Hänninen et al.
IMMUNOLOGICAL REVIEWS (2000)
Share Paper
